Integer Holdings Corporation Reports Third Quarter 2024 Results
24. Oktober 2024 08:00 ET
|
Integer Holdings Corporation
~ Continued strong performance with 3Q24 financial results ~~ Raising midpoint of 2024 operating profit and EPS outlook ~ PLANO, Texas, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Integer Holdings...
STRIDE Fitness Tustin to Hold Global Running Day Celebration featuring Health Experts, Competitions, and Prize Giveaways
06. Juni 2023 17:43 ET
|
STRIDE Fitness Addison
TUSTIN, Calif., June 06, 2023 (GLOBE NEWSWIRE) -- STRIDE Fitness Tustin, a premium boutique fitness studio and member of the Xponential Fitness (NYSE: XPOF) family of brands, is hosting a Global...
$881.28 Mn, Resistance Bands Market to Grow at 4.5% CAGR, Globally, by 2028 - Rising Popularity of Strength Training | Comprehensive Analysis by The Insight Partners
09. Februar 2023 09:18 ET
|
The Insight Partners
New York, Feb. 09, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Resistance Bands Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global Analysis...
CVRx Launches a new Barostim™ Programmer
12. Juli 2022 08:30 ET
|
CVRx, Inc.
MINNEAPOLIS, July 12, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure, has...
The novel cardiovascular drug delivery devices market is projected to grow at a CAGR of 9.3%, till 2035, claims Roots Analysis
05. Juli 2022 10:09 ET
|
Roots Analysis
London, July 05, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Novel Cardiovascular Drug Delivery Devices Market, 2022-2035” report to its list of offerings. In order to...
CVRx® Receives MR-Conditional Labeling Approval for its Barostim™ Heart Failure System
09. Mai 2022 08:30 ET
|
CVRx, Inc.
Heart failure patients implanted with Barostim can now receive conditional MRI scans MINNEAPOLIS, May 09, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), developer of the world’s...
Cardiometabolic Diseases Market Size ($121,804.49Mn by 2028) Lead by Cardiovascular Disease (3.9% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
29. Oktober 2021 09:54 ET
|
The Insight Partners
New York, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Cardiometabolic Diseases Market: Key InsightsAccording to our new research study on Cardiometabolic Diseases Market Size and Forecast to 2028 - COVID-19...
SportsArt Partners with The Imaginarium at I-Square’s ECO gym
22. Februar 2018 09:27 ET
|
SportsArt
ROCHESTER, N.Y., Feb. 22, 2018 (GLOBE NEWSWIRE) -- SportsArt today announces its partnership with The Imaginarium ECO Gym at I-Square. I-Square is a mixed-use development complex that houses The...
BioSig Technologies Announces Results of Independent Product Assessment Study for PURE EP System
26. Oktober 2017 08:00 ET
|
BioSig Technologies, Inc.
Minneapolis, MN, Oct. 26, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
BioSig Technologies Adds Role of Manufacturing Project Leader as Company Continues to Advance Towards Commercialization
24. Oktober 2017 08:00 ET
|
BioSig Technologies, Inc.
Minneapolis, MN, Oct. 24, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...